MSCV(pBabemcs)-human CSF-1(256)-IRES-GFP
(Plasmid
#86795)
-
Purposeretroviral expression of human CSF-1(256)
-
Depositing Labs
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 86795 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneMSCV-IRES-GFP
- Backbone size w/o insert (bp) 6573
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersGFP
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namecolony stimulating factor 1
-
Alt namemacrophage colony stimulating factor 1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1000
-
Mutation256, membrane bound form
-
Entrez GeneCSF1 (a.k.a. CSF-1, MCSF, PG-M-CSF)
-
Tag
/ Fusion Protein
- IRES-GFP (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer pLXSN5; pBABE5
- 3′ sequencing primer pCDH-rev (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThe mcs is from the pBabe vector that was inserted into the MSCV vector to provide more cloning sites, and was developed by Dr Den Besten. The human CSF-1 cDNAs were cloned by the Cetus Company.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MSCV(pBabemcs)-human CSF-1(256)-IRES-GFP was a gift from Martine Roussel & Charles Sherr (Addgene plasmid # 86795 ; http://n2t.net/addgene:86795 ; RRID:Addgene_86795) -
For your References section:
Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1. Heard JM, Roussel MF, Rettenmier CW, Sherr CJ. Oncogene Res. 1987 Sep-Oct;1(4):423-40. PubMed 2966924